Cancer Immunotherapy and Identification of Prognostic and Predictive Biomarkers
Biomed Res Int
.
2018 Mar 20:2018:5184075.
doi: 10.1155/2018/5184075.
eCollection 2018.
Authors
Carmen Criscitiello
1
,
Michele Santangelo
2
,
Fotios Loupakis
3
Affiliations
1
Division of Early Drug Development, European Institute of Oncology, Milano, Italy.
2
Department of Advanced Biomedical Science, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.
3
Medical Oncology Unit 1, Clinical and Experimental Oncology Department, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
PMID:
29750158
PMCID:
PMC5884437
DOI:
10.1155/2018/5184075
No abstract available
Publication types
Editorial
MeSH terms
Biomarkers, Tumor / immunology*
Humans
Immunotherapy / methods*
Neoplasms / diagnosis*
Neoplasms / immunology*
Neoplasms / pathology
Neoplasms / therapy*
Prognosis
Substances
Biomarkers, Tumor